JAMES HEALY - 11 Aug 2022 Form 4 Insider Report for CinCor Pharma, Inc.

Role: Director, 10%+ Owner
Signature: /s/ Nathalie Auber, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 11 Aug 2022
Net transactions value: +$15,180,000
Form type: 4
Filing time: 15 Aug 2022, 15:45:56 UTC
Previous filing: 08 Aug 2022
Next filing: 18 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CINC	Common Stock	Purchase	$15,000,000	+500,000	+9%	$30.00	6,073,949	11 Aug 2022	By Sofinnova Venture Partners X, L.P.	F1
transaction	CINC	Common Stock	Purchase	$180,000	+6,000		$30.00	6,000	11 Aug 2022	By Sofinnova Synergy Master Fund, LP	F2
holding	CINC	Common Stock						29,411	11 Aug 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are directly held by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X"), the general partner of SVP X, may be deemed to have sole voting and dispositive power over such shares. The Reporting Person is a managing member of SM X and may be deemed to share voting and dispositive power over the shares held by SVP X. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
F2	The shares are directly held by Sofinnova Synergy Master Fund, LP (the "Synergy Fund"). Sofinnova Synergy Fund GP, LLC (the "Synergy Fund GP"), the general partner of the Syngery Fund, may be deemed to have sole voting and dispositive power over such shares. The Reporting Person is a managing member of the Synergy Fund GP and may be deemed to share voting and dispositive power over the shares held by the Synergy Fund. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

Content

The shares are directly held by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X"), the general partner of SVP X, may be deemed to have sole voting and dispositive power over such shares. The Reporting Person is a managing member of SM X and may be deemed to share voting and dispositive power over the shares held by SVP X. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

The shares are directly held by Sofinnova Synergy Master Fund, LP (the "Synergy Fund"). Sofinnova Synergy Fund GP, LLC (the "Synergy Fund GP"), the general partner of the Syngery Fund, may be deemed to have sole voting and dispositive power over such shares. The Reporting Person is a managing member of the Synergy Fund GP and may be deemed to share voting and dispositive power over the shares held by the Synergy Fund. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.